Showing results (501-510 of 895) with videos related to

Sort By:
Pageof 90
Drugs in R&D|October 11, 2019
Apremilast Normalizes Gene Expression of Inflammatory Mediators in Human Keratinocytes and Reduces Antigen-Induced Atopic Dermatitis in MicePeter H Schafer, Mary Adams, Gerald Horan, et al.
Drugs in R&D|January 29, 2022
Effect of Severe Renal Impairment on the Safety, Tolerability, and Pharmacokinetics of AMG 986Ashit Trivedi, Omar Mather, Silvia Vega, et al.
Drugs in R&D|February 2, 2022
In Vitro Stability and Recovery Studies of Pimavanserin in Water and in Different Vehicles Orally AdministeredAllan David Bokser, Yvonne Holmes Adegbenle, Vesna Stoisavljevic, et al.
Drugs in R&D|March 13, 2022
A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese SubjectsAshit Trivedi, Omar Mather, Silvia Vega, et al.
Drugs in R&D|March 26, 2022
First-in-Human Phase I Study of the Novel Injectable Calcimimetic Agent Upacicalcet in Healthy Adult Japanese ParticipantsFumihiko Koiwa, Rie Yazawa, Masafumi Fukagawa, et al.
Drugs in R&D|September 21, 2018
Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug ConjugateBilal H Lashari, Yazhini Vallatharasu, Lakshmi Kolandra, et al.
Drugs in R&D|May 30, 2018
Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective StudySebastiano Buti, Maddalena Donini, Melissa Bersanelli, et al.
Drugs in R&D|August 23, 2006
CpG 7909: PF 3512676, PF-3512676
Drugs in R&D|June 3, 2017
A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular CarcinomaTakuya Sho, Mitsuru Nakanishi, Kenichi Morikawa, et al.
Drugs in R&D|June 4, 2017
Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS MalignanciesJohannes Gojo, Robert Sauermann, Ursula Knaack, et al.
Pageof 90